Patent · US Expired

Immediate release tablet

US6521253B1 · kind B1 · utility

20Cited by

4References

22Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Sigbrit Forsman · Lerum, SE
Christer Karlsson · Linköping, SE
Magnus Karlsson · Mölnlycke, SE

Key dates

Filing date	Nov 30, 1999
Grant date	Feb 18, 2003
Priority date	—
Expiry date	Nov 30, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% w/w of the formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.